Advertisement
Advertisement
KAPA
Kairos Pharma, Ltd.
0.60
USDSponsored
0.00
+0.08%
Apr 15, 15:59 UTC -4
Closed
After-Market
0.62
+0.02
+3.00%
KAPA Earnings Reports
Positive Surprise Ratio
KAPA beat 0 of 6 last estimates.
0%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q4 25 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Kairos Pharma, Ltd. earnings per share and revenue
On Mar 31, 2026, KAPA reported earnings of -0.07 USD per share (EPS) for Q4 25, missing the estimate of -0.05 USD, resulting in a -28.68% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +3.54% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Lexaria Bioscience Corp. Common Stock
Report Date
Apr 13, 2026 For Q2 26
Estimate
-$0.09
Actual
-$0.06
Surprise
+38.08%
Sunshine Biopharma Inc.
Report Date
Apr 03, 2026 For Q4 25
Estimate
-$0.27
Actual
-$0.54
Surprise
-96.08%
Pharvaris N.V. Ordinary Shares
Report Date
Apr 02, 2026 For Q4 25
Estimate
-$0.63
Actual
-$0.72
Surprise
-13.69%
Innate Pharma S.A. ADS
Report Date
Apr 01, 2026 For Q1 26
Estimate
-$0.12
Actual
-$0.55
Surprise
-353.80%
FAQ
What were Kairos Pharma, Ltd.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Kairos Pharma, Ltd. reported EPS of -$0.07, missing estimates by -28.68%, and revenue of $0.00, 0% as expectations.
How did the market react to Kairos Pharma, Ltd.'s Q4 2025 earnings?
The stock price moved up 3.54%, changed from $0.56 before the earnings release to $0.58 the day after.
When is Kairos Pharma, Ltd. expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Kairos Pharma, Ltd.'s next earnings report?
Based on --
analysts, Kairos Pharma, Ltd. is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement